Antidepressant dosage and suicidal ideation

JAMA Internal Medicine

Volumn 174, Issue 11, 2014, Pages 1863-1865

  Courtet, Philippe ^a,b   Lopez Castroman, Jorge ^a,b   Jaussent, Isabelle ^a,b   Gorwood, Philip A P M ^c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b FONDATION FONDAMENTAL   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTIONAL DISORDER; FEMALE; FOLLOW UP; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRIORITY JOURNAL; SUICIDAL IDEATION; SUICIDE ATTEMPT; AUTOMUTILATION; CHEMICALLY INDUCED;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; HUMANS; MALE; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS;

EID: 84925282814     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.4509     Document Type: Article

References (4)

1. Miller M, Swanson SA, Azrael D, Pate V, Stürmer T. Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med. 2014;174(6):899-909.
2. Courtet PH, Jaussent I, Lopez-Castroman J, Gorwood PH. Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients. Eur Neuropsychopharmacol. In press. doi:10.1016/j.euroneuro.2014.07.007.
3. Perroud N, Uher R, Marusic A, et al. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial. BMC Med. 2009;7:60. doi:10.1186/1741-7015-7-60.
4. Brent DA, Gibbons R. Initial dose of antidepressant and suicidal behavior in youth: start low, go slow. JAMA Intern Med. 2014;174(6):909-911.